http://www.legislation.gov.uk/id/uksi/2019/744

http://www.legislation.gov.uk/uksi/2019/744/regulation/22

The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

text

text/xml

en

EXITING THE EUROPEAN UNION

MEDICINES

Statute Law Database

2024-05-16

Expert Participation

2020-12-31

These Regulations are made in exercise of the powers conferred by section 8(1) of the European Union (Withdrawal) Act 2018 (c. 16) and amend the Medicines for Human Use (Clinical Trials) Regulations 2004 in order to address failures of retained EU law to operate effectively and other deficiencies (in particular under section 8(2)(a), (b), (c), (d), (f) and (g) and (6)) arising from the withdrawal of the United Kingdom from the European Union.

The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of regulation 56 (transitional provisions)I122